By 2040, new T1D diagnoses are projected to increase by 50%, with an estimated 240,000 new cases in low and middle-income countries. Tragically, people living with T1D in low- and middle-income countries lose 40 years of life versus those in high income countries, due to limited access to diagnosis, insulin, monitoring, education and quality care.*
Learn more about ALIGN-T1D‘s approach to optimize and enhance efforts across T1D and noncommunicable disease (NCD) programs based on government and community-defined priorities to ensure medicines and top-class care are in everyone’s grasp.
*According to estimates from the T1D Index